Stay updated on Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a note indicating PubMed auto-filled publications. Updated the revision to v3.3.2; the old PubMed wording tied to v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:53:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Removed the funding-lapse notice that warned about possible delays in updates and operations. The page no longer displays guidance on government funding status or response times.
    Difference
    0.2%
    Check dated 2025-11-17T17:48:41.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The changes appear to be cosmetic updates to formatting and minor textual tweaks; no core content like eligibility criteria, interventions, outcomes, or enrollment numbers was added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T12:31:06.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    Core content updated with a new diagnosis term and new revision, plus an operating-status notice; a prior cancer term and old version are removed.
    Difference
    1%
    Check dated 2025-10-05T16:44:45.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Terminology updated from 'Plasma cell myeloma' to 'Multiple myeloma' and version bumped from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T09:59:28.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the only other deletion is a minor UI element ('Back to Top') and does not affect core content.
    Difference
    0.1%
    Check dated 2025-09-14T00:11:43.000Z thumbnail image

Stay in the know with updates to Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.